Molecule intelOpportunity: ModerateEssentialCrowded market

Glucose

206 brands · 94 companies · product forms

ATC: B05CX01, V04CA02, V06DC01 3 DRAP alerts

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
90
206
brands
94
companies
Rs 142.78
median price
132
price points
61.08x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 7%

Price room

Across observed sources and strengths
CheapestRs 14.96
MedianRs 142.78
Most expensiveRs 913.75
Spread61.08×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 61.08x across 132 trusted points (Rs 14.96-913.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Glucose — each links to its own medicine page.

Regulatory alerts

Recall exposureSafety exposurelatest 2024-11-29
Recall Alert: Recall Notices for 7 products Issued By Provincial Drug Testing Laboratories
Rapid Alert; Drug Product: Falsified Sojourn ( Sevoflurane) Liquid For Inhalation
Drug Product Recall: Dextrose 25% Infusion (Batch# A042C21) by M/s Otsuka Pakistan Ltd, Hu

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

94 canonical companies and 206 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 61.08x across 132 trusted points (Rs 14.96-913.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

3 DRAP alert(s), latest 2024-11-29 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.